FDA — authorised 25 September 1986
- Application: NDA018874
- Marketing authorisation holder: ABBVIE
- Local brand name: CALCIJEX
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Calcijex on 25 September 1986
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 25 September 1986; FDA authorised it on 12 October 2001; FDA authorised it on 31 December 2002.
ABBVIE holds the US marketing authorisation.